Vladimir Bobek Selected Research

Red Fluorescent Protein

9/2014

In vitro culture and characterization of human lung cancer circulating tumor cells isolated by size exclusion from an orthotopic nude-mouse model expressing fluorescent protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir Bobek Research Topics

Disease

21	Neoplasms (Cancer) 12/2022 - 01/2004
7	Circulating Neoplastic Cells 01/2021 - 01/2013
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2004
4	Prostatic Neoplasms (Prostate Cancer) 05/2013 - 05/2011
3	Lung Neoplasms (Lung Cancer) 09/2014 - 12/2011
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2015
2	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 05/2012
2	Pleural Empyema (Pyothorax) 01/2015 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2015 - 01/2004
2	Suppuration 01/2015 - 01/2013
2	Wounds and Injuries (Trauma) 07/2012 - 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Mesothelioma 05/2014
1	Hemophilia A (Haemophilia) 03/2014
1	Joint Diseases (Joint Disease) 04/2013
1	Synovitis 04/2013
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 07/2012
1	Inflammation (Inflammations) 07/2012
1	Aneuploidy (Aneuploid) 05/2012
1	Duodenal Ulcer (Curling's Ulcer) 04/2011
1	Melanoma (Melanoma, Malignant) 12/2010
1	Colonic Neoplasms (Colon Cancer) 06/2006
1	Necrosis 10/2005
1	Lewis Lung Carcinoma 01/2004

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
5	Green Fluorescent ProteinsIBA 05/2012 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2013
3	Streptokinase FDA Link 01/2013 - 01/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2012
2	ParaffinIBA 01/2021 - 05/2012
2	Biological ProductsIBA 01/2017 - 05/2014
2	Epithelial Cell Adhesion MoleculeIBA 08/2016 - 01/2015
2	Deoxyribonucleases (DNase)FDA Link 01/2015 - 01/2013
2	dornase alfa (Pulmozyme)FDA Link 01/2015 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012 - 01/2012
2	AnticoagulantsIBA 07/2012 - 05/2004
2	Gemcitabine FDA Link 06/2006 - 01/2004
1	SolutionsIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Polysorbates (PSML)FDA Link 01/2017
1	Nucleic AcidsIBA 01/2017
1	Keratin-20 (Cytokeratin 20)IBA 08/2016
1	Keratin-7 (Cytokeratin 7)IBA 08/2016
1	Keratin-19 (Keratin 19)IBA 08/2016
1	Keratin-18 (Keratin 18)IBA 08/2016
1	N-Acylsphingosine GalactosyltransferaseIBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2015
1	Hematoxylin (Haematoxylon)IBA 01/2015
1	Red Fluorescent ProteinIBA 09/2014
1	Radioisotopes (Radionuclides)IBA 04/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2012
1	Nerve Growth Factor (NGF)IBA 07/2012
1	Complementary DNA (cDNA)IBA 01/2012
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2012
1	SuspensionsIBA 11/2011
1	Cimetidine (Biomet)FDA LinkGeneric 04/2011
1	CobaltIBA 10/2005
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2004
1	Heparin (Liquaemin)FDA LinkGeneric 05/2004
1	Warfarin (Coumadin)FDA LinkGeneric 05/2004
1	Pharmaceutical PreparationsIBA 01/2004

Therapy/Procedure

11	Therapeutics 12/2022 - 06/2006
2	Transplantation 12/2011 - 11/2011
1	Neoadjuvant Therapy 01/2021
1	Cytoreduction Surgical Procedures 01/2020
1	Aftercare (After-Treatment) 03/2014
1	Synovectomy 04/2013
1	Investigational Therapies (Experimental Therapy) 07/2012
1	Curettage 05/2012
1	Hysterectomy 05/2012
1	Radiotherapy 06/2006
1	Drug Therapy (Chemotherapy) 06/2006